Research Update: First Human Trials Begin This Summer
by Rakel Apodaca
First Human Clinical Trials Announced
We are excited to announce that this summer, Quantum Health Innovations will begin Phase 1 human clinical trials for our quantum-enhanced stem cell therapy.
Trial Overview
- Condition: Type 1 Diabetes
- Participants: 20 adults aged 25-55
- Location: Research partners in California and Massachusetts
- Duration: 18 months
Safety First
Years of preclinical research have demonstrated the safety profile of our approach. These Phase 1 trials will carefully monitor participants while gathering crucial data on efficacy.
What Success Looks Like
Our goal is to demonstrate that quantum-enhanced islet cells can restore some degree of natural insulin production. Even partial restoration could dramatically improve quality of life for diabetic patients.
Support This Research
Every donation brings us closer to making this therapy available to the millions who need it. Donate today to fund the future of medicine.